{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:11:15Z","timestamp":1791173475651,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jaci.2012.08.032","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T06:02:12Z","timestamp":1351663332000},"page":"1327-1334.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE"],"prefix":"10.1016","volume":"130","author":[{"given":"Linda S.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjuli S.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Creticos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Ambroisine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Melac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.08.032_bib1","unstructured":"Allergies in America: a landmark survey of nasal allergy sufferers. Executive summary: adult. Conducted by HealthSTAR Communications, Inc, in partnership with Schulman, Ronca & Bucuvalas, Inc, 2006. Available at: http:\/\/www.worldallergy.org\/allergic_rhinitis\/resources\/surveyfindings\/. Accessed March 28, 2012."},{"key":"10.1016\/j.jaci.2012.08.032_bib2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaci.2010.12.1106","article-title":"Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006","volume":"127","author":"Salo","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib3","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1001\/archinte.166.16.1744","article-title":"Allergic rhinitis and its consequences on quality of sleep: an unexplored area","volume":"166","author":"Leger","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2012.08.032_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2009.11.010","article-title":"Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study","volume":"104","author":"Hankin","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.08.032_bib5","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1067\/mai.2001.115566","article-title":"Quality of life in adults and children with allergic rhinitis","volume":"108","author":"Meltzer","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2500\/aap.2007.28.3013","article-title":"Allergic rhinoconjunctivitis: burden of disease","volume":"28","author":"Blaiss","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2012.08.032_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2500\/aap.2007.28.2934","article-title":"The burden of allergic rhinitis","volume":"28","author":"Nathan","year":"2007","journal-title":"Allergy Asthma Proc"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.08.032_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaci.2008.06.007","article-title":"Advantages and disadvantages of accelerated immunotherapy schedules","volume":"122","author":"Cox","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2005.10.010","article-title":"Evaluation of near-fatal reactions to allergen immunotherapy injections","volume":"117","author":"Amin","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaci.2007.01.036","article-title":"Allergen immunotherapy: where is it now?","volume":"119","author":"Nelson","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1081-1206(10)60259-1","article-title":"Comparison of allergen immunotherapy practice patterns in the United States and Europe","volume":"103","author":"Cox","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1398-9995.2008.01767.x","article-title":"Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy","volume":"64","author":"Didier","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2222.2008.03152.x","article-title":"Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis","volume":"39","author":"Malling","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A\u00a0statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2222.2011.03700.x","article-title":"The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials","volume":"41","author":"Grouin","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","article-title":"Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis","volume":"21","author":"Juniper","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2009.07.054","article-title":"Recommendations for appropriate sublingual immunotherapy clinical trials","volume":"124","author":"Casale","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1081-1206(10)61339-7","article-title":"The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials","volume":"96","author":"Rodrigo","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2009.11.020","article-title":"Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class","volume":"104","author":"Benninger","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2008.01808.x","article-title":"Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials","volume":"63","author":"Penagos","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib27","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2007.01374.x","article-title":"Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis","volume":"62","author":"Pradalier","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","article-title":"Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis","volume":"128","author":"Didier","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaci.2010.03.014","article-title":"Human IgE antibody serology: a primer for the practicing North American allergist\/immunologist","volume":"126","author":"Hamilton","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0091-6749(99)70419-7","article-title":"A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy","volume":"103","author":"Wood","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2008.01.023","article-title":"A comparison of skin prick tests, intradermal skin tests, and specific IgE in the diagnosis of mouse allergy","volume":"121","author":"Sharma","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2009.02.012","article-title":"Evaluation of serum s-IgE\/total IgE ratio in predicting clinical response to allergen-specific immunotherapy","volume":"123","author":"Di Lorenzo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000121468","article-title":"Specific immunotherapy for common grass pollen allergies: pertinence of a five grass pollen vaccine","volume":"146","author":"Moingeon","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2012.08.032_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1398-9995.2011.02745.x","article-title":"Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy","volume":"67","author":"Shamji","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.08.032_bib35","unstructured":"ORALAIR 100 IR & 300 IR sublingual tablets: summary of product characteristics. Available at: www.stallergenes.com\/fileadmin\/images\/corporate\/gallery\/Documents_pdf\/2010-10-Oralair_fin_MRP_RCP.pdf. Accessed March 28, 2012."}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912014479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912014479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:36:11Z","timestamp":1758789371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674912014479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0091674912014479"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.08.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717964604.793467817","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717964604.793468353","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717964604.793499614","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717964604.793466656","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}